ZOMETA® For Treatment Of Skeletal-Related Events From Bone Metastases | Site Map

View videos on bone
metastases and the ZOMETA
mechanism of action

Learn more about the ZOMETA(zoledronic acid) mechanism of action

For non-U.S. Healthcare Professionals: Get information about ZOMETA and its product characteristics

Learn more about ZOMETA product characteristics

ZOMETA is the current standard of care for the prevention of skeletal-related events (SREs)

ZOMETA^® Home Page

About ZOMETA

Breast Cancer
Lung Cancer
Prostate Cancer
Renal Cell Carcinoma
Multiple Myeloma

ZOMETA Patient Case Studies

Breast Cancer
Lung Cancer
Prostate Cancer
Renal Cell Carcinoma
Multiple Myeloma

ZOMETA Dosing & Administration

Dosing For Bone Metastases
Dosing For TIH

ZOMETA Safety & Tolerability

Acute Phase Reactions
Renal Safety
Dental Health

ZOMETA Clinical News

Recent Publications
Key Clinical Trial Publications
ZOMETA Virtual Exhibit Booth

ZOMETA For Your Patients

Professional Resource Center

Press Releases
Creatinine Clearance Calculator
Videos
Calendar of Events
Additional Resources
ZOMETA Challenge!

ZOMETA Around the World — Country Site

Disclaimer: This is an international website for ZOMETA^® (zoledronic acid) and is intended for healthcare professionals outside the US. If you are a US resident, please click on the US flag at the top right corner of this page. The information on this site is not country-specific and may contain information that is outside the approved indications in the country in which you are located.